LYEL - Chief Scientific Officer at Lyell Immunopharma Exercises Options Worth $1.54M | Benzinga
Gary Lee, Chief Scientific Officer at Lyell Immunopharma (NASDAQ:LYEL), reported a large exercise of company stock options on November 21, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Lee, Chief Scientific Officer at Lyell Immunopharma, a company in the Health Care sector, just exercised stock options worth 800,000 shares of LYEL stock with an exercise price of $6.04.
Lyell Immunopharma shares are trading down 1.03% at $1.92 at the time of this writing on Tuesday morning. Since the current price is $1.92, this makes Lee's 800,000 shares worth $1,536,000.